Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients Harry W. Herr OriginalPaper Pages: 84 - 88
Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder Olof AlfthanKari JauhiainenFinnbladder Research Group OriginalPaper Pages: 89 - 95
Biologic response modifiers in the management of superficial bladder cancer Scott SerelsJonathan Fleischmann OriginalPaper Pages: 96 - 102
The use of the BTA Test in the detection of persistent or recurrent transitional-cell cancer of the bladder Michael F. Sarosdy OriginalPaper Pages: 103 - 106
The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder Scott W. ShelfoMark S. Soloway OriginalPaper Pages: 107 - 111
Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer Carlos Cordon-CardoJoel Sheinfeld OriginalPaper Pages: 112 - 119
Applications of telomerase in urologic oncology Jaime LandmanElizabeth KavalerBrian C. -S. Liu OriginalPaper Pages: 120 - 124
New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder P. WardeM. K. Gospodarowicz OriginalPaper Pages: 125 - 133
Update of urethra-sparing approaches in cystectomy in women Arnulf StenzlKarl ColleselliGeorg Bartsch OriginalPaper Pages: 134 - 138
New approaches in the treatment of metastatic transitional-cell cancer of the bladder David A. CorralChristopher J. Logothetis OriginalPaper Pages: 139 - 143
Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation U. JonasK. Höfnerparticipants of the international study group Free Paper Pages: 144 - 151
